非整倍体植入前遗传学检测:证据综述
本文综述了针对非整倍体的植入前遗传学检测(PGT-A)结合全面染色体筛查的已发表随机对照试验,并讨论了嵌合体胚胎问题。多数试验因仅纳入预后良好、卵巢储备正常且可活检胚胎数多的患者而受批评。PGT-A在常规IVF人群中不提高每周期持续妊娠率,但对特定正常卵巢储备患者是胚胎选择工具,且应由经验丰富的IVF诊所实施;无整倍体胚胎时,经遗传咨询后可考虑低水平嵌合体胚胎移植。
要点
- PGT-A在常规IVF人群中不改善每起始周期的持续妊娠率。
- PGT-A可能适用于卵巢储备正常、预后良好的特定患者。
- 无整倍体胚胎时,经遗传咨询可优先考虑低水平嵌合体胚胎移植。
核心结论
- PGT-A在常规IVF人群中不提高每起始周期的持续妊娠率,但对特定正常卵巢储备患者是胚胎选择工具。
研究设计与样本
- 本文综述了所有已发表的关于PGT-A结合全面染色体筛查的随机对照试验。
- 2014至2016年间美国约开展了95,000个PGT周期,其中大多数针对非整倍体。
主要发现
- 大多数试验仅纳入预后良好、卵巢储备正常且产生大量可活检胚胎的患者。
- PGT-A在常规IVF人群中不改善每起始周期的持续妊娠率。
- PGT-A似乎是对特定正常卵巢储备患者进行胚胎选择的良好工具。
临床怎么用
- PGT-A应仅由经验丰富的IVF诊所实施。
- 若无整倍体胚胎可用,经适当遗传咨询后可考虑并优先移植低水平嵌合体胚胎。
局限性
- 多数已发表随机对照试验仅纳入预后良好患者,限制了结果在一般IVF人群中的推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preimplantation genetic testing for aneuploidy was developed as an invasive embryo-selection technique and is extensively used in in vitro fertilization (IVF) cycles. Around 95,000 preimplantation genetic testing cycles were carried out in the United States between 2014 and 2016, the majority of which were performed for aneuploidy. The objective of preimplantation genetic testing for aneuploidy is to select for transfer a euploid embryo, after embryo biopsy and cytogenetic analysis. The current technique consists of applying comprehensive chromosome screening on trophectoderm cells after blastocyst-stage embryo biopsy. This article reviews all the published randomized controlled trials on preimplantation genetic testing for aneuploidy with comprehensive chromosome screening and comments on the subject of embryo mosaicism detected by this technique. Most of these trials have been criticized because they only included good prognosis patients having normal ovarian reserve producing a high number of embryos available for biopsy. Preimplantation genetic testing for aneuploidy does not improve ongoing pregnancy rates per cycle started when routinely applied on the general IVF population but seems to be a good tool of embryo selection for a selected category of patients with normal ovarian reserve, yet should be only practiced by experienced IVF clinics. If no euploid embryo is available after preimplantation genetic testing for aneuploidy, a low-level mosaic embryo can be considered and prioritized for transfer after appropriate genetic counseling.
引用
- Dahdouh EM. Preimplantation Genetic Testing for Aneuploidy: A Review of the Evidence. Obstet Gynecol. 2021. PMID: 33543903. doi:10.1097/AOG.0000000000004295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。